8. Cancer Stem Cells

  1. Uma Lakshmipathy,
  2. Jonathan D. Chesnut and
  3. Bhaskar Thyagarajan
  1. Scott J. Dylla,
  2. In-Kyung Park and
  3. Austin L. Gurney

Published Online: 17 APR 2009

DOI: 10.1002/9780470454923.ch8

Emerging Technology Platforms for Stem Cells

Emerging Technology Platforms for Stem Cells

How to Cite

Dylla, S. J., Park, I.-K. and Gurney, A. L. (2009) Cancer Stem Cells, in Emerging Technology Platforms for Stem Cells (eds U. Lakshmipathy, J. D. Chesnut and B. Thyagarajan), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470454923.ch8

Editor Information

  1. Primary and Stem Cell Systems, Invitrogen Corporation, 5781 Faraday Avenue, Carlsbad, CA 92008, USA

Author Information

  1. OncoMed Pharmaceuticals Inc., 800 Chesapeake Drive, Redwood City, CA 94063, USA

Publication History

  1. Published Online: 17 APR 2009
  2. Published Print: 18 MAR 2009

ISBN Information

Print ISBN: 9780470146934

Online ISBN: 9780470454923



  • cancer stem cell (CSC) and cancer stem cell (CSC) hypothesis;
  • coupling investigation of CSC with normal stem cells;
  • biochemical pathway monitoring


This chapter contains sections titled:

  • Defining CSC Identity

  • Coupling Investigation of CSC with That of Normal Stem Cells

  • Discovery of New and Improved CSC Markers

  • Monitoring Biochemical Pathways

  • Dispersion of Solid Tissue to Obtain Single Cells

  • Isolation of Defined Cell Populations

  • Assays for CSC

  • Steps Forward for Cancer Stem Cell Biology

  • References